EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease

Jun Young Kim iD, Byung Soo Kwan iD, Jung Hwan Cho, Hye In Kim, Nak Gyeong Ko, Mihyeon Jin, Ok Jae Lee iD

Journal of Clinical Medicine · 07.02.2025 · 14 (4) · 1073

DOI: 10.3390/jcm14041073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.02.2025. Verfasst von Jun Young Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Gyeongsang National University Graduate School, Jinju 52727, Republic of Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Previous studies suggested a link between Helicobacter pylori (H. pylori) infection and steatotic liver disease, now termed metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to identify the association of active H. pylori infection and the new concept of MASLD in a longitudinal cohort.

Methods

We reviewed 1497 health examinees who had two endoscopic biopsies for H. pylori activity without hepatic steatosis at the baseline abdominal ultrasonography. Subjects were classified into four groups based on H. pylori activity. Multivariable Cox models assessed the link between active H. pylori infection status and incident MASLD.

Results

Over a median follow-up of 31.1 months, 247 subjects (16.5%) developed MASLD. The groups were: H. pylori naïve (n = 57, 15.6%), de novo (n = 31, 15.3%), eradicated (n = 32, 16.1%), and persistent (n = 127, 17.4%). The H. pylori persistent group had a higher risk of MASLD compared to naïve group (hazard ratio: 1.41; 95% confidence interval: 1.01–1.96; p-value = 0.045). The association between H. pylori infection and incident MASLD was significant only with ongoing infection.

Conclusions

Persistent H. pylori infection increases the risk of MASLD, indicating that active infection may contribute to MASLD development. Eradicating active H. pylori infection might help lower the incidence of MASLD.

Schlagwörter

Stichwörter der Autor:innen

Helicobacter pyloricohort studymetabolic dysfunction-associated steatotic liver diseasenon-alcoholic fatty liver disease

Autor:innen und Institutionen

  • Department of Medicine, Gyeongsang National University Graduate School, Jinju 52727, Republic of Korea.
  • Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea.
  • Department of Research & Support, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea.
  • Department of Internal Medicine, Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
  • Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.

ORCID-Profile: Jun Young Kim, Byung Soo Kwan, Ok Jae Lee

Zitieren

APA

Kim, J. Y., Kwan, B. S., Cho, J. H., Kim, H. I., Ko, N. G., Jin, M., & Lee, O. J. (2025). Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine, 14(4), 1073. https://doi.org/10.3390/jcm14041073

Vancouver

Kim JY, Kwan BS, Cho JH, Kim HI, Ko NG, Jin M, et al. Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine. 2025;14(4):1073. doi:10.3390/jcm14041073

BibTeX
@article{Kim2025,
  author = {Kim, Jun Young and Kwan, Byung Soo and Cho, Jung Hwan and Kim, Hye In and Ko, Nak Gyeong and Jin, Mihyeon and Lee, Ok Jae},
  title = {Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1073},
  doi = {10.3390/jcm14041073}
}
Kostenlos starten →